Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Novartis AG

    OTC: NVSEF · Real-Time Price · USD
    119.18
    1.18 (1.00%)
    At close: Jun 13, 2025, 2:50 PM

    Novartis Statistics

    Share Statistics

    Novartis has 1.9B shares outstanding. The number of shares has increased by -3.01% in one year.

    Shares Outstanding

    n/a
    		 1.9B

    Shares Change (YoY)

    n/a
    		 -3.01%

    Shares Change (QoQ)

    n/a
    		 -3.01%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 1.69B

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 1.28M, so 0.06% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.28M

    Short % of Shares Out

    n/a
    		 0.06%

    Short % of Float

    n/a
    		 0.06%

    Short Ratio (days to cover)

    n/a
    		 73.05

    Valuation Ratios

    The PE ratio is 16.24 and the forward PE ratio is 13.2. Novartis's PEG ratio is -0.72.

    PE Ratio

    n/a
    		 16.24

    Forward PE

    n/a
    		 13.2

    PS Ratio

    n/a
    		 3.75

    Forward PS

    n/a
    		 3.7

    PB Ratio

    n/a
    		 4.4

    P/FCF Ratio

    n/a
    		 14.05

    PEG Ratio

    n/a
    		 -0.72
    Financial Ratio History

    Enterprise Valuation

    Novartis has an Enterprise Value (EV) of 213.73B.

    EV / Sales

    n/a
    		 4.13

    EV / EBITDA

    n/a
    		 10.32

    EV / EBIT

    n/a
    		 12.13

    EV / FCF

    n/a
    		 15.48

    Financial Position

    The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.71.

    Current Ratio

    n/a
    		 1.04

    Quick Ratio

    n/a
    		 0.84

    Debt / Equity

    n/a
    		 0.71

    Debt / EBITDA

    n/a
    		 1.51

    Debt / FCF

    n/a
    		 2.26

    Interest Coverage

    n/a
    		 14.46

    Financial Efficiency

    Return on Equity is 27.11% and Return on Invested Capital is 15.55%.

    Return on Equity

    n/a
    		 27.11%

    Return on Assets

    n/a
    		 11.68%

    Return on Invested Capital

    n/a
    		 15.55%

    Revenue Per Employee

    n/a
    		 $681,601.94

    Profits Per Employee

    n/a
    		 $157,360.67

    Employee Count

    n/a
    		 75,883

    Asset Turnover

    n/a
    		 0.51

    Inventory Turnover

    n/a
    		 2.25

    Taxes

    Income Tax

    n/a
    		 1.7B

    Effective Tax Rate

    n/a
    		 12.47%

    Stock Price Statistics

    The stock price has increased by 16.87% in the last 52 weeks. The beta is 0.53, so Novartis's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.53

    52-Week Price Change

    n/a
    		 16.87%

    50-Day Moving Average

    n/a
    		 109.98

    200-Day Moving Average

    n/a
    		 107.67

    Relative Strength Index (RSI)

    n/a
    		 69.61

    Average Volume (20 Days)

    n/a
    		 46,990

    Income Statement

    In the last 12 months, Novartis had revenue of 51.72B and earned 11.94B in profits. Earnings per share was 5.92.

    Revenue

    n/a
    		 51.72B

    Gross Profit

    n/a
    		 38.9B

    Operating Income

    n/a
    		 14.54B

    Net Income

    n/a
    		 11.94B

    EBITDA

    n/a
    		 20.71B

    EBIT

    n/a
    		 14.65B

    Earnings Per Share (EPS)

    n/a
    		 5.92
    Full Income Statement

    Balance Sheet

    The company has 11.46B in cash and 31.26B in debt, giving a net cash position of -19.8B.

    Cash & Cash Equivalents

    n/a
    		 11.46B

    Total Debt

    n/a
    		 31.26B

    Net Cash

    n/a
    		 -19.8B

    Retained Earnings

    n/a
    		 46.46B

    Total Assets

    n/a
    		 102.25B

    Working Capital

    n/a
    		 1.01B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 17.62B and capital expenditures -3.81B, giving a free cash flow of 13.8B.

    Operating Cash Flow

    n/a
    		 17.62B

    Capital Expenditures

    n/a
    		 -3.81B

    Free Cash Flow

    n/a
    		 13.8B

    FCF Per Share

    n/a
    		 6.84
    Full Cash Flow Statement

    Margins

    Gross margin is 75.2%, with operating and profit margins of 28.12% and 23.09%.

    Gross Margin

    n/a
    		 75.2%

    Operating Margin

    n/a
    		 28.12%

    Pretax Margin

    n/a
    		 26.37%

    Profit Margin

    n/a
    		 23.09%

    EBITDA Margin

    n/a
    		 40.05%

    EBIT Margin

    n/a
    		 28.12%

    FCF Margin

    n/a
    		 26.69%

    Dividends & Yields

    NVSEF pays an annual dividend of $3.96, which amounts to a dividend yield of 3.3%.

    Dividend Per Share

    n/a
    		 $3.96

    Dividend Yield

    n/a
    		 3.3%

    Dividend Growth (YoY)

    n/a
    		 5.8%

    Payout Ratio

    n/a
    		 61.94%

    Earnings Yield

    n/a
    		 6.16%

    FCF Yield

    n/a
    		 7.12%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for NVSEF.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $56.24

    Lynch Upside

    n/a
    		 -52.49%

    Graham Number

    n/a
    		 53.91

    Graham Upside

    n/a
    		 -54.46%

    Stock Splits

    The last stock split was on Oct 4, 2023. It was a forward split with a ratio of 211:200.

    Last Split Date

    n/a
    		 Oct 4, 2023

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 211:200

    Scores

    Altman Z-Score

    n/a
    		 3.16

    Piotroski F-Score

    n/a
    		 7

    Add to Watchlist